PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.6K Buy
+145
New +$24.9K 0.01% 380
2025
Q1
Sell
-13
Closed -$1.72K 500
2024
Q4
$1.72K Buy
+13
New +$1.83K ﹤0.01% 426
2023
Q1
Sell
-20
Closed -$2.63K 332
2022
Q4
$2.63K Buy
+20
New +$2.58K ﹤0.01% 236

Other funds holding IBB

PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s IBB Position: Q2 2026 in Review

PENSION & WEALTH MANAGEMENT ADVISORS, INC. opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 145 shares worth $27.6K. The stake represents 0.01% of the portfolio and ranks #380 among its holdings. This is a return to the name: PENSION & WEALTH MANAGEMENT ADVISORS, INC. previously reported a position in IBB as recently as Q4 2024.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in IBB in Q4 2022 and has held it in 3 quarters since. 601 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. held 145 shares of iShares Biotechnology ETF worth $27.6K as of Q2 2026.
  • iShares Biotechnology ETF was a new PENSION & WEALTH MANAGEMENT ADVISORS, INC. position in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s portfolio in Q2 2026, its #380 holding.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 3 quarters since.
  • 601 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q2 2026, filed 7 Aug 2026.